BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30391395)

  • 21. Urological manifestations of Duchenne muscular dystrophy.
    Askeland EJ; Arlen AM; Erickson BA; Mathews KD; Cooper CS
    J Urol; 2013 Oct; 190(4 Suppl):1523-8. PubMed ID: 23357214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Opportune Time for Newborn Screening in Duchenne Muscular Dystrophy.
    Chrzanowski SM; McAnally MM; Kang PB
    JAMA Neurol; 2021 Aug; 78(8):901-902. PubMed ID: 34152378
    [No Abstract]   [Full Text] [Related]  

  • 23. Urinary prostaglandin metabolites as Duchenne muscular dystrophy progression markers.
    Takeshita E; Komaki H; Tachimori H; Miyoshi K; Yamamiya I; Shimizu-Motohashi Y; Ishiyama A; Saito T; Nakagawa E; Sugai K; Sasaki M
    Brain Dev; 2018 Nov; 40(10):918-925. PubMed ID: 30006121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Composite biomarkers for assessing Duchenne muscular dystrophy: an initial assessment.
    Shklyar I; Pasternak A; Kapur K; Darras BT; Rutkove SB
    Pediatr Neurol; 2015 Feb; 52(2):202-5. PubMed ID: 25447928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Duchenne muscular dystrophy born prematurely showed normal CK value until 35 weeks of gestation age].
    Morisawa T; Yagi M; Yoshii K; Takeshima Y; Matsuo M
    No To Hattatsu; 2004 Jul; 36(4):342-3. PubMed ID: 15272621
    [No Abstract]   [Full Text] [Related]  

  • 26. Physical Activity in Boys With Duchenne Muscular Dystrophy Is Lower and Less Demanding Compared to Healthy Boys.
    Heutinck L; Kampen NV; Jansen M; Groot IJ
    J Child Neurol; 2017 Apr; 32(5):450-457. PubMed ID: 28112012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Duchenne or Meryon muscular dystrophy?
    Drouin E; Péréon Y
    Mol Genet Metab; 2014 Dec; 113(4):241-2. PubMed ID: 25458520
    [No Abstract]   [Full Text] [Related]  

  • 28. Duchenne muscular dystrophy in a female child.
    Viswanathan V
    Indian Pediatr; 2002 Oct; 39(10):980-1; author reply 981. PubMed ID: 12428052
    [No Abstract]   [Full Text] [Related]  

  • 29. Development and content validation of the Muscular Dystrophy Child Health Index of Life with Disabilities questionnaire for children with Duchenne muscular dystrophy.
    Propp R; McAdam L; Davis AM; Salbach NM; Weir S; Encisa C; Narayanan UG
    Dev Med Child Neurol; 2019 Jan; 61(1):75-81. PubMed ID: 30058069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnosis and natural history of Duchenne muscular dystrophy].
    Desguerre I; Laugel V
    Arch Pediatr; 2015 Dec; 22(12 Suppl 1):12S24-30. PubMed ID: 26773582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Analysis of 18 cases of Becker muscular dystrophy].
    Bernal Sánchez-Arjona M; Sanz-Fernández G; Travado-Soria P; Fernández-García R; Chinchón-Lara I; Antiñolo G; Bautista-Lorite J
    Rev Neurol; 2004 Jun 1-15; 38(11):1090-2. PubMed ID: 15202090
    [No Abstract]   [Full Text] [Related]  

  • 32. Duchenne muscular dystrophy: a 30-year population-based incidence study.
    Dooley J; Gordon KE; Dodds L; MacSween J
    Clin Pediatr (Phila); 2010 Feb; 49(2):177-9. PubMed ID: 20080524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The dystrophy of Duchenne.
    Jay V; Vajsar J
    Lancet; 2001 Feb; 357(9255):550-2. PubMed ID: 11229686
    [No Abstract]   [Full Text] [Related]  

  • 34. Duchenne muscular dystrophy in a female child.
    Joshi S
    Indian Pediatr; 2002 Jan; 39(1):98. PubMed ID: 11805363
    [No Abstract]   [Full Text] [Related]  

  • 35. Developmental and behavioral disorders grown up: duchenne muscular dystrophy.
    Birnkrant JM; Bennett DS; Noritz GH; Birnkrant DJ
    J Dev Behav Pediatr; 2011 Oct; 32(8):609-15. PubMed ID: 21836526
    [No Abstract]   [Full Text] [Related]  

  • 36. A bedside measure of body composition in Duchenne muscular dystrophy.
    Elliott SA; Davidson ZE; Davies PS; Truby H
    Pediatr Neurol; 2015 Jan; 52(1):82-7. PubMed ID: 25301226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatty liver disease and hypertransaminasemia hiding the association of clinically silent Duchenne muscular dystrophy and hereditary fructose intolerance.
    Paolella G; Pisano P; Albano R; Cannaviello L; Mauro C; Esposito G; Vajro P
    Ital J Pediatr; 2012 Oct; 38():64. PubMed ID: 23114028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Approaching therapies for boys with Duchenne muscular dystrophy. Parent Project Muscular Dystrophy. Annual conference in Cincinnati/Ohio, 13-16 July 2006.
    Scheuerbrandt G
    Acta Myol; 2006 Oct; 25(2):77-97. PubMed ID: 18593009
    [No Abstract]   [Full Text] [Related]  

  • 39. Duchenne muscular dystrophy and concomitant metastatic alveolar rhabdomyosarcoma.
    Rossbach HC; Lacson A; Grana NH; Barbosa JL
    J Pediatr Hematol Oncol; 1999; 21(6):528-30. PubMed ID: 10598666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wolff-Parkinson-White syndrome in Duchenne muscular dystrophy.
    Fayssoil A; Amara W; Annane D; Orlikowski D
    Int J Cardiol; 2013 Aug; 167(3):e53-4. PubMed ID: 23642616
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.